September 03, 2026 – Melbourne -- SIBIONICS showcased its AI-driven continuous glucose monitoring (CGM) sensor, GS3, at the joint IDF-WPR, ADC and Metabolic Diseases 2026 congress in Melbourne, held August 18-21 and featuring a company booth, a scientific symposium and on-site interviews with certified diabetes educators (CDEs).
GS3 sensor delivers 14-day monitoring with a 2.9mm profile
The factory-calibrated GS3 sensor is designed for continuous glucose tracking over a 14-day cycle while minimizing physical discomfort through its slim 2.9mm profile. SIBIONICS positioned the device as an extension of its work in brain-computer interfaces, including a retinal prosthesis for patients with retinitis pigmentosa, adapting high-precision biosensor and signal-processing engineering into a more accessible CGM platform.
Clinical experts outline integrated CGM, ketone monitoring and AI ecosystem
At a symposium titled "Beyond Glucose: The Integrated Future of CGM, CKM and AI in Diabetes," co-organized by SIBIONICS and Air Liquide Healthcare, session chair Professor Sofianos Andrikopoulos, CEO of the Australian Diabetes Society Group, moderated three clinical perspectives. Professor David O'Neal of the University of Melbourne and deputy director of the Australian Centre for Accelerating Diabetes Innovations reviewed emerging clinical evidence on continuous glucose and ketone body monitoring. Associate Professor Shannon Lin of the University of Technology Sydney examined how CGM data can move beyond visualization toward personalized, predictive support. Professor Wei Qiang, associate chief physician and deputy director of Endocrinology and Metabolism at the First Affiliated Hospital of Xi'an Jiaotong University, described an AI-driven ecosystem linking reliable detection, contextual data and continuous learning.
Diabetes educators cite AI-assisted spike detection and simplified meal logging
In anonymous interviews conducted at the booth, CDEs described GS3 as small, lightweight, comfortable and easy to set up. They highlighted the sensor's AI-assisted glucose spike detection, simplified meal logging and food analysis linking glucose trends to meal context. Educators emphasized that personalization, clear carbohydrate estimates and clinically useful event timelines are needed for AI to complement — rather than replace — professional diabetes care.
SIBIONICS plans integration with ketone monitoring and insulin delivery
SIBIONICS said it intends to integrate its sensor platform with continuous ketone body monitoring, insulin delivery systems and additional AI-driven diabetes technologies. The company's stated goal is building an ecosystem that accelerates the pathway from raw data to clinical understanding and from understanding to patient action.